Explore the latest news about Venture Partners at CU Boulder and keep up to date on the impact CU's startups and technologies are making.

Artistic illustration of research and discovery

New Buff Venture Fund makes landmark investments in CU Boulder startups

March 21, 2023

Five promising startups spun out of CU Boulder comprise the first cohort of companies to receive investment from the Buff Venture Fund. The fund is the newest opportunity for CU Boulder startups to access critical funding on the path to success. The Buff Venture Fund is administered by Buff Gold Ventures, which has a formal partnership with Venture Partners at CU Boulder.

Teams hold prize checks on stage

NVC prize nights spotlight—and fund—female founders and climate solutions

March 14, 2023

On two exciting nights of pitches and prizes, ten startups brought a broad range of ideas to the stage, including how to live and garden more sustainably, how to deal with the downsides of social media, how to offer practical prosthetics for kids—and sustainable water filters and hydroponic produce for all. Across the two events, eight teams took home a total of $20,000 to develop their ideas further.

Jun Ye

New program Embark to pair entrepreneurs with CU Boulder technologies

March 9, 2023

Wanted: entrepreneurs ready to launch startups based on innovations created in CU Boulder’s research labs. The Embark Deep Tech Startup Creator is a new program created by Venture Partners at CU Boulder, the commercialization arm of CU, to match business minds outside the university with breakthrough inventions created within its walls.

Scientist working in a laboratory

Venture Partners 2022 Annual Report highlights a groundbreaking innovation pipeline

March 2, 2023

CU Boulder has developed a groundbreaking pipeline to translate research into real-world impact, as highlighted in the 2022 Annual Report of Venture Partners at CU Boulder, the university’s commercialization arm.

Man standing in a soybean field

New ‘magic beans’ produce ingredients for cancer treatments, vaccines and more

March 1, 2023

As a first-generation college student turned molecular biologist, Brian DeDecker imagines a day when humble soybeans beans, which his family has grown for generations, pack a bounty of therapeutic but hard-to-obtain natural compounds.

Woman presents business plan

2023 Destination Startup® drives investment in intermountain west university innovations

Feb. 28, 2023

The intermountain west innovation ecosystem came together at the fifth annual Destination Startup® showcase on Feb. 15 and 16, hosted by Venture Partners at CU Boulder. In a highly competitive field, 21 university ventures from intermountain west research institutions were selected to present at the showcase.

Vegan hamburger

Meati Foods announces its inaugural “Meati Culinary Collective” led by world-renowned celebrity chefs

Feb. 27, 2023

VegWorld Magazine—Meati Foods, a CU Boulder spinout and the producer of delicious animal-free, whole-food protein, this week debuted an evolving chef partnership series coined the “Meati Culinary Collective,” featuring Meati’s mushroom root-based creations as prepared by a diverse roster of celebrated chefs.

Stan Hickory

New Venture Challenge’s Hickory steps into Innovation & Entrepreneurship director role

Feb. 22, 2023

The Research & Innovation Office has announced several leadership transitions within the campuswide Innovation & Entrepreneurship Initiative, with Stan Hickory stepping into the role of director of the initiative, a position held by Chris Gustavson since 2019.

Illustration of DNA

To Health: Xalud Therapeutics is bringing gene therapy to the masses

Feb. 8, 2023

GEN—Xalud Therapeutics, a CU Boulder spinout, is developing a non-viral DNA-delivered therapy platform to treat conditions caused by pathologic inflammation

Microscopic picture of bacteria

We’re not so different: Bacterial weapons could help fight human diseases

Feb. 8, 2023

New research from CU Boulder could ultimately pave the way to novel approaches for treating a host of human diseases, from autoimmune disorders like Rheumatoid arthritis and Crohn’s disease to neurodegenerative diseases like Parkinson’s disease.

Pages